d*r
2 楼
RNA一大早跌了80%..
http://www.businessweek.com/news/2013-09-20/prosensa-shares-plu
Bloomberg News
Prosensa Shares Plunge as Muscular Dystrophy Drug Fails in Trial
By Makiko Kitamura September 20, 2013
Prosensa Holding NV (RNA:US) plunged after the Dutch company’s experimental
muscular dystrophy drug failed to help patients walk better in a clinical
trial.
Prosensa sank 71 percent to $7 at 7:55 a.m. New York time in trading (RNA:US
) before U.S. exchanges opened. The company is based in Leiden, the
Netherlands, and listed on the Nasdaq Stock Market. Prosensa is developing
the treatment, drisapersen, with GlaxoSmithKline Plc. (GSK)
Drisapersen failed to help patients more than a placebo in a test of six-
minute walking distance, the companies said in a statement today.
STORY: Former Lehman CFO Erin Callan's Never Going Back
Duchenne muscular dystrophy is a neuromuscular disease with no known cure
that affects one in 3,500 newborn boys.
Glaxo rose 0.1 percent to 1,578 pence in London. Sarepta Therapeutics Inc.
is developing a competing drug.
Prosensa sold shares in June in an initial public offering (RNA:US) at $13
each. The company had a market value of $840.1 million based on yesterday’s
closing share price of $24.
http://www.businessweek.com/news/2013-09-20/prosensa-shares-plu
Bloomberg News
Prosensa Shares Plunge as Muscular Dystrophy Drug Fails in Trial
By Makiko Kitamura September 20, 2013
Prosensa Holding NV (RNA:US) plunged after the Dutch company’s experimental
muscular dystrophy drug failed to help patients walk better in a clinical
trial.
Prosensa sank 71 percent to $7 at 7:55 a.m. New York time in trading (RNA:US
) before U.S. exchanges opened. The company is based in Leiden, the
Netherlands, and listed on the Nasdaq Stock Market. Prosensa is developing
the treatment, drisapersen, with GlaxoSmithKline Plc. (GSK)
Drisapersen failed to help patients more than a placebo in a test of six-
minute walking distance, the companies said in a statement today.
STORY: Former Lehman CFO Erin Callan's Never Going Back
Duchenne muscular dystrophy is a neuromuscular disease with no known cure
that affects one in 3,500 newborn boys.
Glaxo rose 0.1 percent to 1,578 pence in London. Sarepta Therapeutics Inc.
is developing a competing drug.
Prosensa sold shares in June in an initial public offering (RNA:US) at $13
each. The company had a market value of $840.1 million based on yesterday’s
closing share price of $24.
x*n
3 楼
我上上周team member说马上安排onsite,结果上周没消息,这周到现在还没消息。
w*x
6 楼
明天问吧,表现得积极一点。good luck。
f*i
7 楼
打电话问了HR,说还没有安排,又给HM发了邮件骚扰,继续漫长的等待。。。
我人生中最美好的时间都在等待中过去了。。。
我人生中最美好的时间都在等待中过去了。。。
相关阅读
有人申了HHMI international pre-doctoral fellowship吗?极少量细胞提取DNA国内副教也是千老,国内博后是万老转行和绿卡问题Natural Killer Cells NK-92 有人了解么?哈尔滨兽医研究所的 Science paper咱们生物学家是不是可以提出一个狗类安全等级分类paper help气愤:干得好,反被开除帮朋友问一下fellowship能不能同实验室转让第五届北京大学生命科学院校友会年会 (7月 20日,圣地亚哥)Nature Biotechnology牛吗?跟nature什么关系?其实清华校长给状元打电话也是有传统的着急问!请不到PhD答辩的committee member怎么办?求文献生物女博士求助最近被很多人鄙视了咨询基因敲除大鼠和转基因大鼠的价格这种情况一定要做Southern Blot吗会搞生物的基本上应该会八卦吧